2017 Cancer Annual Report | Page 8

Primary Site Table - 2016
Summary by Location of Cancer
Sex
Class of
Status
Stage at Diagnosis - Analytic
Primary Site Total (%) M F Analytic NA Alive Expired Stg Stg I Stg Stg Stg
ORAL CAVITY & PHARYNX 39 (1.7%) 25 14 27 12 30 9 0 2 2 5 14
363 (16.2%) 185 178 298 65 265 98 10 48 53 69 82
Colon Excluding Rectum 119 (5.3%) 55 64 98 21 98 21 3 17 18 30 28
Rectum & Rectosigmoid 47 (2.1%) 22 25 41 6 41 6 3 7 9 12 7
276 (12.3%) 139 137 241 35 179 97 6 72 22 39 91
SOFT TISSUE 18 (0.8%) 8 10 16 2 17 1 0 3 2 4 2
SKIN EXCLUDING BASAL & SQUAMOUS 102 (4.6%) 55 47 74 28 93 9 11 26 8 12 9
1 (0.0%) 1 0 1 0 1 0 0 0 0 0 1
BREAST 432 (19.3%) 6 426 361 71 407 25 50 156 99 30 21
FEMALE GENITAL SYSTEM 158 (7.1%) 0 158 129 29 136 22 1 57 12 17 21
MALE GENITAL SYSTEM 181 (8.1%) 181 0 113 68 170 11 2 23 51 13 18
URINARY SYSTEM 146 (6.5%) 107 39 127 19 130 16 36 46 14 12 9
5 (0.2%) 2 3 3 2 5 0 0 0 0 0 0
BRAIN & OTHER NERVOUS 113 (5.0%) 48 65 87 26 94 19 0 0 0 0 0
ENDOCRINE SYSTEM 120 (5.4%) 34 86 95 25 118 2 0 37 6 10 4
LYMPHOMA 107 (4.8%) 70 37 80 27 92 15 0 7 8 18 26
Hodgkin Lymphoma 12 (0.5%) 9 3 8 4 12 0 0 0 2 4 1
Non-Hodgkin Lymphoma 95 (4.2%) 61 34 72 23 80 15 0 7 6 14 25
MYELOMA 29 (1.3%) 16 13 20 9 26 3 0 0 0 0 0
Myeloma 29 (1.3%) 16 13 20 9 26 3 0 0 0 0 0
65 (2.9%) 43 22 41 24 54 11 0 0 0 0 0
Lymphocytic Leukemia 35 (1.6%) 25 10 19 16 34 1 0 0 0 0 0
Myeloid & Monocytic 26 (1.2%) 15 11 21 5 16 10 0 0 0 0 0
MESOTHELIOMA 3 (0.1%) 3 0 2 1 2 1 0 0 0 0 1
MISCELLANEOUS 81 (3.6%) 48 33 58 23 50 31 0 0 0 0 0
2239 971 466 1869 370 116 477 277 229 299
DIGESTIVE SYSTEM
RESPIRATORY SYSTEM
BASAL & SQUAMOUS
EYE & ORBIT
LEUKEMIA
TOTAL
1268 1773
| 7 |